Dociparstat
CMX-DS-003
Phase 3 small_molecule terminated
Quick answer
Dociparstat for Acute Myeloid Leukemia is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated